Integrated pan-cancer multi-omics profiling and experimental validation identify LSM12 as a prognostic biomarker and candidate therapeutic target in human cancers. - Eldeen MA; Refaat AM; Ahmed HEM; Hassan HM; Alshehri M; Fayad E; Jafri I; Alshaya DS; Babteen NA; Sait LM; Alqahtani LS; Kim B (BMC cancer, 2026)